
Thoromontax®
Metabolic biostimulant of the reproductive processes - coadjuvant in Infertility therapy for females and males.





Each mL contains: Sodium iodide (sodium content) 50,000 mg Potassium iodide (potassium content) 50.000 mg Potassium (as chloride) 4,282 mg Zinc (as chloride) 0.135 mg Manganese (as chloride) 0.885 mg Magnesium (as chloride) 19,640 mg Copper (as chloride) 0.220 mg Iron (as chloride) 12,960 mg Molybdenum (as ammonium molybdate) 0.018 mg Cobalt (as chloride) 0.164 mg Calcium (as gluconate) 300.000 mg Excipients q.s.ad. 1,000 mL.
Thoromontax® is indicated in the following pathologies: - Infertility due to deficiencies, estrous cycle alterations due to unidentified causes and asymptomatic infertility. - In cases of anestrus, associated with hormonal and/or other necessary treatment. - As an adjuvant in the treatment of ovarian disorders: underdeveloped and inactive ovaries, acceleration of follicle rupture, ovarian malfunction, ovarian cysts, changes in uterine tone and lack of ovarian release. - Genitourinary infections (metritis, vaginitis, mastitis) accompanied by antibiotherapy treatment. - Prophylactic in pregnant animals for an adequate fetal development and prevention of abortion. - Delayed puberty, infertility, disordered estrus, absence of conception, low conception rates, prolonged gestation periods and delivery of dead or weak fetuses, hairless calves and goiter. - Bulls and males in general, with reduced libido, poor testicular development and seminal quality. Reduced sperm production and delayed sperm maturation. - Metabolic diseases, deficiency diseases, alteration of normal bone growth, swollen and painful joints and decrease of hemoglobin. Complementary treatment in cases of labor paralysis and puerperal hypocalcemia. - Respiratory infectious diseases: bronchitis and pneumonia, phlegmons, other infections, together with antibiotherapy. - Mineral deficiency in the formula. - Hemoparasitic diseases, blood formation disorders, among others. - Growing animals showing undefined symptoms, such as decreased rate of development, lack of appetite, changes in bone structure, hooves, skin and coat.
SENASA Registry: F.107.001.I.00089